Pfizer falls 12 pct in Europe after key drug fails
613559
Shares in Pfizer Inc fell 12 percent in  Europe on Monday after the world's biggest drugmaker scrapped  development of its most important experimental medicine.
333055
New prescriptions for Pfizer Inc.'s  arthritis drug Celebrex fell 56 percent last week after the  company released data showing the drug may increase the risk of  heart attacks and strokes, according to Verispan, a market  research company.
57452
Shares in Anglo-Swedish drug giant AstraZeneca drop more than 8% in value after the failure of its Iressa drug in a major clinical trial.
624082
Pfizer Inc., the world&#39;s largest drugmaker, said third-quarter earnings jumped 49 percent after merger-related expenses fell and sales of the cholesterol treatment Lipitor rose.
414238
Stocks inched lower on Friday,  pressured by a sharp drop in Pfizer Inc. PFE.N after the drug  maker said patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
28046
More than $31bn (Â£16bn) was yesterday knocked off the value of Pfizer, the world&#39;s largest pharmaceutical company and maker of Viagra, after doubts surfaced over the safety of one of its key drugs.
56524
Shares in US drugmaker Pfizer plunge after it halts development of its most important experimental drug.
322396
European stock markets fell strongly in early trading, weighed down by Wall Street's poor end to last week, with pharmaceuticals particularly vulnerable.
489823
Shares in Pfizer Inc, the world's biggest drugmaker, fell more than 10 percent in early trade in Europe on Monday, after news it had scrapped its most important experimental drug.
560123
US stocks fell on Friday dragged down by a string of negative reports from drug makers, with Pfizer Inc. (PFE.N: Quote, Profile, Research) , AstraZeneca Plc.
238512
Shares of Pfizer Inc., the world's largest drugmaker, sank Monday on news that the company had halted development of a key new cholesterol treatment that was heralded as its engine for future growth as the company struggles with stagnant sales.
667642
In a surprising setback for the  world's largest drugmaker, Pfizer Inc.  halted  development on Saturday of its top experimental medicine, the  cholesterol drug torcetrapib, due to safety concerns.
204220
Pfizer Inc.'s decision to scrap development of a crucial medicine sent its shares plummeting yesterday as analysts fretted about its future and speculated about which companies it might purchase to shore up its pipeline.
479171
NEW YORK  - Pfizer dismissed a report on the safety of its pain reliever Bextra, but the new controversy weighed on the stock price of the US pharmaceutical giant.
249393
NEW YORK - Pfizer Inc.  said on Thursday third-quarter earnings fell sharply, hurt by a $2.8 billion charge to end its involvement with its poorly-selling Exubera inhaled insulin drug.
202222
Stocks were little changed on Friday,  recovering after a sharp early drop on news from Pfizer Inc.  PFE.N that patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
690389
The Dow Jones industrial average fell on Friday after Pfizer Inc. (PFE.N: Quote, Profile, Research) shares opened nearly 19 percent down on trial data for its popular arthritis drug Celebrex that showed increased risk of heart attack.